Drug Trial Radar · NCT02481219
Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure
Last checked: Nov 19, 2026Latest source record: Mar 7, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
122
Actual
Start
May 2015
Primary completion
Jan 2016
Study completion Feb 2016
Sponsor
- Lead sponsor
- Medtronic - MITGIndustry
- Sponsor type
- Industry
- First posted
- Jun 25, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 50 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is designed to determine the optimal bowel preparation regimen for PillCam® COLON 2 Capsule Endoscopy System (CCE) procedures in average risk patients. Patients will be randomized to receive one of two bowel preparation regimens prior to PillCam CCE.
Conditions
- Colorectal Cancer Screening
Interventions
PillCam® COLON 2 procedure-CONTROLDevice
Senna tabletsDrug
PEGDrug
MetoclopramideDrug
ErythromycinDrug
SUPREP oral sulfate solutionDrug
BisacodylDrug
SUPREP oral sulfate solution with GastrografinDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Bowel Cleansing Level of Two Different Bowel Preparation Methods for PillCam® Colon Capsule Endoscopy (CCE)Time frame: Within two weeks of study procedure
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Pinnacle Research Group, LLC
Anniston, Alabama
Indiana University Hospital
Indianapolis, Indiana
Indianapolis Gastroenterology and Hepatology
Indianapolis, Indiana
Dayton Gastroenterology
Dayton, Ohio
Thomas Jefferson University
Philadelphia, Pennsylvania
Franklin Gastroenterology, PLLC
Franklin, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.